ATE322895T1 - Coenzym q10 zur behandlung von erkrankungen der augen - Google Patents
Coenzym q10 zur behandlung von erkrankungen der augenInfo
- Publication number
- ATE322895T1 ATE322895T1 AT02425777T AT02425777T ATE322895T1 AT E322895 T1 ATE322895 T1 AT E322895T1 AT 02425777 T AT02425777 T AT 02425777T AT 02425777 T AT02425777 T AT 02425777T AT E322895 T1 ATE322895 T1 AT E322895T1
- Authority
- AT
- Austria
- Prior art keywords
- coenzyme
- treatment
- eye diseases
- pathologies
- degenerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001RM000755A ITRM20010755A1 (it) | 2001-12-20 | 2001-12-20 | Uso del chinone q10 per il trattamento delle malattie oculari. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE322895T1 true ATE322895T1 (de) | 2006-04-15 |
Family
ID=11455922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02425777T ATE322895T1 (de) | 2001-12-20 | 2002-12-17 | Coenzym q10 zur behandlung von erkrankungen der augen |
Country Status (6)
Country | Link |
---|---|
US (1) | US7029672B2 (de) |
EP (1) | EP1321138B1 (de) |
AT (1) | ATE322895T1 (de) |
DE (1) | DE60210568T2 (de) |
ES (1) | ES2262777T3 (de) |
IT (1) | ITRM20010755A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRM20030153A1 (it) * | 2003-04-03 | 2004-10-04 | Exall S R L | Formulazione idrosolubile contenente ubichinone per uso oftalmico. |
DK1718283T3 (da) | 2004-01-22 | 2013-04-22 | Univ Miami | Topisk co-enzyme Q10 formuleringer og fremgangsmåder for anvendelse. |
US20060127384A1 (en) * | 2004-12-09 | 2006-06-15 | Sergio Capaccioli | Coenzyme Q10 as antiapoptotic agent |
US8557733B2 (en) | 2006-10-20 | 2013-10-15 | Mitotech S.A. | Composition for regenerating and stimulating growth of plants and for adapting plants to different stress factors |
EP2119436A4 (de) * | 2006-10-20 | 2010-03-03 | Ltd Liability Company Mitotech | Pharmazeutische zusammensetzungen zur verhinderung und behandlung von augenkrankheiten |
US8349902B2 (en) | 2007-01-29 | 2013-01-08 | Mitotech Sa | Pharmaceutical compositions useful for preventing and treating oncological diseases |
WO2008094061A1 (fr) | 2007-01-29 | 2008-08-07 | Limited Liability Company 'mitotechnology' | Compositions pharmaceutiques et cosmétiques servant à accélérer le processus de cicatrisation de plaies et autres lésions superficielles |
CA2823407C (en) | 2007-03-22 | 2016-10-18 | Berg Pharma Llc | Topical formulations having enhanced bioavailability |
US9439916B2 (en) | 2007-04-11 | 2016-09-13 | Mitotech Sa | Composition for decelerating the aging in the organism and for extending the life time thereof and the use of said composition |
ES2577539T3 (es) * | 2007-04-20 | 2016-07-15 | Senju Pharmaceutical Co., Ltd. | Promotor de la formación de neuritas |
US8518915B2 (en) | 2007-06-29 | 2013-08-27 | Mitotech Sa | Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases |
WO2009126764A1 (en) | 2008-04-11 | 2009-10-15 | Cytotech Labs, Llc | Methods and use of inducing apoptosis in cancer cells |
WO2010056145A1 (ru) | 2008-11-12 | 2010-05-20 | Общество С Ограниченной Ответственностью "Митотехнология" | Способ умеренного повышения протонной проводимости биологических мембран при помощи митохондриально- адресованных делокализованных катионов |
JP2012526828A (ja) | 2009-05-11 | 2012-11-01 | バーグ バイオシステムズ,エルエルシー | エピメタボリックシフター、多次元細胞内分子、または環境影響因子を使用する代謝性障害の治療方法 |
EP2441453B1 (de) | 2009-06-10 | 2014-11-26 | Mitotech SA | Pharmazeutische zusammensetzung für die human- und tiermedizinische ophthalmologie |
KR20120125980A (ko) | 2009-11-13 | 2012-11-19 | 리미티드 라이어빌러티 컴퍼니 미토테크 | 미토콘드리아 표적화된 항산화제에 기초한 약학적 물질 |
ES2664793T3 (es) * | 2010-03-12 | 2018-04-23 | Berg Llc | Formulaciones intravenosas de coenzima Q10 (CoQ10) y métodos de uso de las mismas |
ES2762451T3 (es) | 2011-04-04 | 2020-05-25 | Berg Llc | Tratamiento de tumores del sistema nervioso central con coenzima Q10 |
EA031399B1 (ru) | 2011-06-03 | 2018-12-28 | Общество С Ограниченной Ответственностью "Митотех" | Изготовление и использование пероральных фармацевтических композиций на основе митохондриально-адресованных антиоксидантов |
JP5932993B2 (ja) | 2011-06-17 | 2016-06-08 | バーグ エルエルシー | 吸入可能な医薬組成物 |
EA032775B1 (ru) | 2013-04-08 | 2019-07-31 | Берг Ллк | Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10 |
JP6595478B2 (ja) | 2013-09-04 | 2019-10-23 | バーグ エルエルシー | コエンザイムq10の連続注入によるがんの治療方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US119936A (en) * | 1871-10-17 | Improvement in fire-extinguishers | ||
FR2608045B1 (fr) * | 1986-12-12 | 1990-03-02 | Chauvin Laboratoires | Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome |
JPH10509732A (ja) * | 1994-12-06 | 1998-09-22 | ライアン・ファーマスーティカルス・インコーポレーテッド | 水溶性ユビキノン組成物、プロドラッグおよびこれに関連した方法 |
US20020032160A1 (en) | 1995-02-24 | 2002-03-14 | Nyce Jonathan W. | Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels |
IT1299578B1 (it) * | 1998-07-24 | 2000-03-16 | Rosario Brancato | Uso dell'ubichinone per la produzione di un farmaco efficace nella prevenzione e nel trattamento della degenerazione maculare correlata |
IT1304406B1 (it) | 1998-10-21 | 2001-03-19 | Danital Italia S R L | Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3. |
WO2000057871A2 (en) * | 1999-03-30 | 2000-10-05 | Purdue Research Foundation | Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof |
IT1307281B1 (it) * | 1999-11-25 | 2001-10-30 | Simonelli Giuseppe | Uso di ubichinone q10 per il trattamento locale e la prevenzione dipatalogie oftalmologiche secondarie alla terapia fotorefrattiva, |
US6441050B1 (en) * | 2000-08-29 | 2002-08-27 | Raj K. Chopra | Palatable oral coenzyme Q liquid |
US6403116B1 (en) | 2000-11-03 | 2002-06-11 | Triarco Inductries, Inc. | Coenzyme Q10 formulation |
-
2001
- 2001-12-20 IT IT2001RM000755A patent/ITRM20010755A1/it unknown
-
2002
- 2002-12-17 DE DE60210568T patent/DE60210568T2/de not_active Expired - Fee Related
- 2002-12-17 ES ES02425777T patent/ES2262777T3/es not_active Expired - Lifetime
- 2002-12-17 EP EP02425777A patent/EP1321138B1/de not_active Expired - Lifetime
- 2002-12-17 AT AT02425777T patent/ATE322895T1/de not_active IP Right Cessation
- 2002-12-20 US US10/323,820 patent/US7029672B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7029672B2 (en) | 2006-04-18 |
US20030118576A1 (en) | 2003-06-26 |
EP1321138A1 (de) | 2003-06-25 |
DE60210568T2 (de) | 2007-05-24 |
ITRM20010755A1 (it) | 2003-06-20 |
DE60210568D1 (de) | 2006-05-24 |
ES2262777T3 (es) | 2006-12-01 |
EP1321138B1 (de) | 2006-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE322895T1 (de) | Coenzym q10 zur behandlung von erkrankungen der augen | |
EA200601223A1 (ru) | Производные сульфонамида для лечения заболеваний | |
IS7215A (is) | Aðferðir til að meðhöndla nýæðarsjúkdóma í augum | |
MXPA04006184A (es) | Compuestos derivados de 1h-pirazolilo, para el uso en enfermedades asociadas con el receptor 5-ht2c. | |
CY1108514T1 (el) | Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων | |
MY135841A (en) | Novel benzodioxoles | |
ATE361288T1 (de) | N-(3,-dimethylindolin-6-yl)ä2-ä(4- | |
CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
WO2005080324A8 (en) | Sulfonamide derivatives for the treatment of diseases | |
MY144483A (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
MXPA05009535A (es) | Compuestos de acido n - alquil - hidroxamico - isoindolilo y sus usos farmaceuticos. | |
WO2005075450A3 (en) | Spiro-benzodioxoles and their use as cb1 antagonists | |
BR0211972A (pt) | Composição oftálmica | |
EA200801711A1 (ru) | Пролекарства возбуждающих аминокислот | |
TW200502221A (en) | Novel lactams and uses thereof | |
EA200600071A1 (ru) | Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором | |
TW200505865A (en) | Compounds useful for the treatment of diseases | |
WO2020165839A9 (en) | Formulations of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile | |
ATE491453T1 (de) | Verwendung von 4-aminochinolin-verbindungen zur behandlung entzündlicher erkrankungen des auges | |
ATE437855T1 (de) | (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit | |
HK1110768A1 (en) | 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses | |
DE602005014632D1 (de) | Pyrrol- bzw. imidazolamide zur behandlung von obesitas | |
ATE407126T1 (de) | Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on | |
WO2023246870A9 (zh) | 吲哚化合物的制备、应用及用途 | |
ATE464048T1 (de) | Behandlung von alzheimer-krankheit und verwandten zuständen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |